RxDoctor Payments Data

Chelsea Bohac

Adult Health · Katy, TXNPI 1780108175

Payments from drug & device makers

$3,199in general payments, 2019–2025

Across 172 payments — averaging $18.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$967
  • Novo Nordisk$340
  • Antares Pharma, Inc.$313
  • AstraZeneca$256
  • Abbott$187
  • Dexcom, Inc.$144
  • plus $992 from 21 others

What the payments were for

  • Food & beverage$3,199100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,199 in reported general payments places this provider in the 80th percentile of 933 adult health providers in Texas.

See all adult health providers in Texas

Medicare billing

Part B allowed, 2024
$104,175
Medicare patients
91
Services billed
1,698

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide74$109,315
TrulicityDulaglutide19$24,466
MounjaroTirzepatide11$16,833
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$10,695
RelpaxEletriptan Hydrobromide11$10,676
Gabapentin83$1,322
Bupropion XlBupropion Hcl45$1,262
Atorvastatin Calcium79$1,146
Celecoxib24$826
Tamsulosin Hcl53$777
Montelukast Sodium70$667
Ondansetron OdtOndansetron25$644
Clonazepam71$627
Metoprolol Succinate69$551
Pantoprazole Sodium41$540

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$340$109,31574 claims
Lilly USA, LLCTrulicity, Mounjaro$142$41,29930 claims
GSKTrelegy Ellipta$25$10,69513 claims
PfizerRelpax$29$10,67611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 933 adult health providers in Texas.

Other adult health in Katy

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →